Evidence map›Paper›PMID 30767842›Full record

ArticleInfection control and hospital epidemiology2019

Inappropriate ceftriaxone use in outpatient acute respiratory infection management.

Laura M King, Pamela Talley, Marion A Kainer, Christopher D Evans, Cullen Adre, Lauri A Hicks, Katherine E Fleming-Dutra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection control and hospital epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Changes in outpatient antibiotic prescribing for acute respiratory illnesses, 2011 to 2018.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura M KingDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases,Centers for Disease Control and Prevention,Atlanta, Georgia.ORCID 0000-0002-7785-4712
Pamela TalleyHealthcare Associated Infections and Antimicrobial Resistance Program,Tennessee Department of Health,Nashville, Tennessee.
Marion A KainerHealthcare Associated Infections and Antimicrobial Resistance Program,Tennessee Department of Health,Nashville, Tennessee.
Christopher D EvansHealthcare Associated Infections and Antimicrobial Resistance Program,Tennessee Department of Health,Nashville, Tennessee.
Cullen AdreHealthcare Associated Infections and Antimicrobial Resistance Program,Tennessee Department of Health,Nashville, Tennessee.
Lauri A HicksDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases,Centers for Disease Control and Prevention,Atlanta, Georgia.
Katherine E Fleming-DutraDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases,Centers for Disease Control and Prevention,Atlanta, Georgia.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAmbulatory Care FacilitiesAnti-Bacterial AgentsCeftriaxoneDrug UtilizationFemaleHumansMaleMiddle AgedOutpatientsPrescription Drug MisuseRespiratory Tract InfectionsUnited StatesYoung AdultAnti-Bacterial AgentsCeftriaxone

Identifiers

PMID30767842
PMCPMC6533902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.